Targeting Histone Deacetylases in Diseases: Where Are We?-Reference-Cited by-同舟云学术

Targeting Histone Deacetylases in Diseases: Where Are We?

Published:2015-07 Issue:1 Volume:23 Page:99-126
ISSN:1523-0864
Container-title:Antioxidants & Redox Signaling
language:en
Short-container-title:Antioxidants & Redox Signaling

Author:

Benedetti Rosaria¹,Conte Mariarosaria¹,Altucci Lucia¹²

Affiliation:

1. Department of Biochemistry, Biophysics, and General Pathology, Seconda Università degli Studi di Napoli, Napoli, Italy.

2. Istituto di Genetica e Biofisica “Adriano Buzzati-Traverso,” Napoli, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Clinical Biochemistry,Molecular Biology,Physiology,Biochemistry,Cell Biology,Clinical Biochemistry,Molecular Biology,Physiology,Biochemistry

Link

http://www.liebertpub.com/doi/pdf/10.1089/ars.2013.5776

Reference265 articles.

1. Class I histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin's lymphoma

2. Phase I Trial of a New Schedule of Romidepsin in Patients with Advanced Cancers

3. Modulation of Epigenetic Targets for Anticancer Therapy: Clinicopathological Relevance, Structural Data and Drug Discovery Perspectives

4. Natural Killer Cell–Mediated Lysis of Hepatoma Cells via Specific Induction of NKG2D Ligands by the Histone Deacetylase Inhibitor Sodium Valproate

5. Development of the pan-DAC inhibitor panobinostat (LBH589): Successes and challenges

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in nanotherapeutic strategies for Huntington's disease: Design, delivery, and neuroprotective mechanisms;Coordination Chemistry Reviews;2025-01

2. Protein lysine acetyltransferase CBP/p300: A promising target for small molecules in cancer treatment;Biomedicine & Pharmacotherapy;2024-02

3. Design, Synthesis, and Antiproliferative Activity of Selective Histone Deacetylases 6 Inhibitors Containing a Tetrahydropyridopyrimidine Scaffold;Molecules;2023-10-29

4. Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications;MedComm;2023-05-02

5. Metabolic reprogramming by immune-responsive gene 1 up-regulation improves donor heart preservation and function;Science Translational Medicine;2023-02-08